|
|
||||||||
Eur J Cardiothorac Surg 2000;18:187-193
© 2000 Elsevier Science NL
a Department of Cardiothoracic Surgery, University of Vienna, AKH Vienna, Währingergürtel 1820, 1090 Vienna, Austria
b Department of Cardiology, University of Innsbruck, Innsbruck, Austria
c Department of Cardiothoracic and Vascular Anaesthesia and Intensive Care, University of Vienna, 1090 Vienna, Austria
Received 12 October 1999; received in revised form 28 February 2000; accepted 7 March 2000.
Corresponding author. Tel.: +43-1-40400-5620/5630; fax: +43-1-440-5309
e-mail: seitel{at}magnet.at
| Abstract |
|---|
|
|
|---|
Key Words: Right bundle branch block Coronary artery bypass grafting Myocardial ischemia Enzyme analysis Holter monitoring
| 1. Introduction |
|---|
|
|
|---|
Caspi et al. reported that 62% of patients with new postoperative LBBB and only 20% with RBBB showed elevated creatine kinase (CK)-MB levels of more than 5% of total serum CK and abnormal timerelease curves [1]. These data, however, were not directly compared with those of patients with either perioperative myocardial infarction (MI) or an uneventful postoperative course. In contrast, Hake et al. demonstrated impaired left ventricular function and elevated enzyme levels in patients with new, permanent RBBB following CABG [7]. In patients with coronary artery disease, the occurrence of even transient intraventricular conduction disturbances including RBBB is a reliable indicator of myocardial ischemia during exercise testing [8].
The goal of the present study was to investigate the significance of transient or permanent RBBB in the diagnosis of perioperative myocardial ischemia. One hundred and seventy-three consecutive patients undergoing CABG were monitored by means of 12-lead ECG and Holter monitoring, and serial assessment of serum enzyme levels. Data of patients with new RBBB were then compared with those having either an uneventful postoperative course, or demonstrating electrocardiographic signs of MI or transient myocardial ischemia (TIE).
| 2. Patients and methods |
|---|
|
|
|---|
Patients were premedicated with midazolam and received standard general anesthesia with midazolam, etomidate, fentanyl and pancuronium. Controlled mechanical ventilation with oxygen/air was provided to achieve normoventilation. The cardiopulmonary bypass circuit consisted of a hollow-fiber oxygenator (Bard HF 5701, C.R. Bard Inc., Havorhill, MA) primed with Ringer's lactate 2000 ml, mannitol 20 g, heparin 8000 IU (Immuno, Vienna, Austria) and aprotinin 1 000 000 IU (Trasylol Bayer, Leverkusen, Germany). Flow during CPB was maintained at 2.5 l/min per m2 and mild hypothermia (34°C) was employed. Myocardial protection consisted of cold, intermittent blood cardioplegia administered ante- (induction) and retrogradely. Body rewarming began during completion of the last distal anastomose. A partial occlusion clamp was used for the proximal anastomoses. For continuous monitoring of perioperative arterial and pulmonary artery pressure, a radial artery cannula and a SwanGanz catheter (percutaneously into the pulmonary artery via the jugular vein) were inserted preoperatively.
2.1. Holter monitoring and electrocardiographic recordings
Two methods were used to assess perioperative electrocardiographic changes.
(1) Continuous three-channel Holter monitoring was performed using Marquette Holter Recorders (Series 8500). The evaluation was performed on a semiautomatic basis using a Marquette Laser Holter XP device. Monitoring began 2 h after opening of the aortic cross-clamp and lasted for 48 h. The electrodes were placed so that channels 13 approximated ECG-leads V2, V5 and aVF, respectively.
(2) Twelve-lead ECG recordings were performed shortly before and 2, 4, 6, 8, 12, 16, 20, 24, 36 and 48 h after operation, as well as every day until the sixth postoperative day.
All Holter tapes and ECG-recordings were reviewed by the same investigator. Five different forms of perioperative myocardial events were defined by the combined analysis of electrocardiographic and Holter recordings using the following criteria.
2.1.1. Transient ischemic event (TIE)
Horizontal or downsloping ST-segment depression of
1 mm and lasting at least 1 min measured 6080 ms from the J-point in at least one Holter channel with no signs of evolving MI.
2.1.2. Myocardial infarction
(a) Persistent typical ST-segment elevation of
2 mm, measured 6080 ms from the J-point in at least one Holter channel and development of a new Q wave (>0.04 s in duration and more than one quarter of the following R wave in amplitude) in the corresponding 12-lead ECG after 6 days and/or during the 48 h observation period after surgery.
(b) Persistent negative coronary T wave of >3 mm in 12-lead ECG during the 48-h postoperative observation period and/or 6 days after surgery without occurrence of a new Q wave.
2.1.3. Right bundle branch block
New occurrence of minimum QRS duration of
0.12 s with typical RSR configuration in V1 and/or in V2 and with deep, late S waves in I, V5 and/or V6 for more than 48 h duration and at discharge-ECG (permanent), and less than 48 h in duration (transient).
2.1.4. Left anterior hemiblock (LAHB)
New occurrence of a frontal axis>-30° with a small Q in I and aVL, small R waves in II, III and aVF, and S waves in V1V6.
2.1.5. Left axis deviation
New occurrence of a frontal axis>-30° with a small Q in I and aVL, small R waves in II, III, and aVF, and no S waves in V1V6.
2.1.6. Left bundle branch block
New occurrence of minimum QRS duration of >0.12 s with an absent Q wave, a notched or slurred R in I, V5 and/or V6, and wide right precordial S waves.
2.2. Biochemical analysis
Creatine kinase (CK, units/l, normal values: 070) and the MB-isoenzyme of CK (CK-MB, units/l, normal values: 010) were assessed immediately before surgery and 4, 8, 12, 16, 20, 24, 36 and 48 h after aortic cross-clamp time using enzymatic fluorometric methods.
2.3. Statistical analysis
All data are presented as mean±standard deviation (SD). An analysis of variance (ANOVA) was used to compare CK and CK-MB values. Since those values demonstrated a non-normal distribution, adequate transformations were performed: peak values were assessed in a logarithmic fashion and compared. (significance level: P<0.05). In addition, the time corrected area under the curve (AUC) for CK and CK-MB data was assessed in a logarithmic fashion and compared (significance level: P<0.05). Pairwise comparisons were performed using the correction of Tukey (significance level: P<0.05). Spot-checks of peak values were carried out using empiric quantiles and summarized using box-and-whiskers plots.
For statistical data analysis, the SPSS 9.0 (SPSS Inc.) statistical package was used.
| 3. Results |
|---|
|
|
|---|
|
|
|
|
|
The time courses of CK-MB values for all groups until 48 h after the operation are depicted in Fig. 3 . Due to the inadequate efficiency of analyzing single values at respective time points, the AUC for each group was evaluated. The AUC was proportional to the mean values over the 48-h observation period. According to this analysis, all four groups were significantly different among each other (overall: P<0.001; Tukey-corrected P<0.001 for all paired comparisons).
|
| 4. Discussion |
|---|
|
|
|---|
Apart from diagnostic methods with high sensitivity and specificity such as myocardial uptake of technetium-99m pyrophosphate on a scintigram or transesophageal echocardiography for detection of regional functional changes, which cannot be used for routine follow-up, the analysis of ECG and enzyme release constitute the standard methods for the diagnosis of postoperative myocardial ischemia. In most reports, new MI (defined as the development of a new Q wave with or without preceding ST segment elevation) remains the gold standard for defining the postoperative complication of myocardial ischemia. However, various reports also emphasized the possible diagnostic significance of the new occurrence of conduction disturbances such as RBBB or LBBB [13,7].
Whereas the significance of LBBB as an indicator of perioperative myocardial ischemia is widely accepted [1,7], the diagnostic significance of the occurrence of new RBBB after coronary bypass grafting remains controversial [27]. In nonsurgical patients the occurrence of transient or permanent RBBB at rest or during exercise is usually associated with small vessel disease concomitant to fibrodegenerative changes, severe proximal left anterior descending coronary artery disease or induced by right ventricular involvement in inferior wall left ventricular MI [8,1315]. Especially in combination with MI, RBBB is also associated with poorer prognosis and increased in-hospital and 1-year postdischarge mortality [1416].
Following coronary bypass grafting, increased CK-MB activities, impaired postoperative regional myocardial function, greater demand for catecholamines or complicated postoperative course have primarily been observed in patients who developed a new permanent RBBB [2,7].
The results of the present study clearly show that new transient and/or permanent RBBB are associated with markedly higher perioperative CK-MB levels than in patients with an uneventful postoperative course. Consequently, the occurrence of new RBBB must be linked to myocardial cell necrosis and appears indicative of perioperative myocardial ischemia. However, since perioperative CK-MB values of patients with ECG-proven transmural MI were higher than in patients with new RBBB, the extent of the ischemic damage of myocardial cells is certainly smaller in these patients and does not reach the average extent of cell necrosis induced by a transmural MI.
The significance of a certain conduction disturbance as an indicator of myocardial ischemia must be based on a reliable, ischemia-specific diagnostic parameter in order to compare its diagnostic value with other, widely acknowledged, indicators of perioperative myocardial ischemia. In this study, myocardial ischemia was defined either by the occurrence of new MI or of a TIE. Perioperative time courses and peak values of CK and CK-MB as indicators of the extent of myocardial cell necrosis were then used to compare patients with new MI or TIE to those with conduction disturbances.
The diagnosis of MI was based on the combined analysis of repeated ECG and continuous Holter recordings, and required the existence of a persistent ST segment elevation of >2 mm prior to the development of a new Q wave in the corresponding lead. In addition, a negative coronary T wave of >3 mm persisting throughout the 6-day observation period was also classified as MI [11]. Whereas this definition of MI is widely accepted, conflicting reports have been published about the diagnostic accuracy of serum enzymes for the detection of significant myocardial ischemia, such as MI.
Although CK-MB release seems to be a reliable biochemical indicator for perioperative MI, the lack of a generally accepted cutoff value (defined as peak activity or total quantity) and the interpatient variability of CK-MB levels compromise its diagnostic sensitivity [17,18]. Nevertheless, in this study, both CK as well as CK-MB levels were markedly higher in patients with perioperative MI assessed by the combined analysis of ECG and Holter monitoring recordings than in patients with either an uneventful postoperative course or with TIE only. Given the assumption that serum enzyme levels reflect, at least to a certain degree, the amount of damaged myocardial tissue [17], the significantly higher CK and CK-MB values of patients with RBBB as compared to those with no event or only TIE indicate that RBBB does reflect the occurrence of myocardial ischemia in patients undergoing coronary bypass grafting.
In contrast to other reports, we did not detect any relevant differences in postoperative enzyme release patterns between patients with transient or permanent RBBB [2,7]. However, since the latest follow-up ECG in this study was only 6 days after surgery, our definition of permanent RBBB as any RBBB lasting at least 48 h during the postoperative period may have overestimated the true number of patients with permanent RBBB.
Several reasons have been implicated to cause postoperative conduction disturbances such as a higher incidence of preoperative MI, a higher number of diseased coronary vessels and applied bypass grafts, longer aortic cross-clamp time and the use of cold potassium cardioplegia [1,3,5,1922]. In the present study, however, we were unable to identify risk factors for the perioperative occurrence of RBBB. Whereas the relatively low number of patients in our study with new RBBB did not allow a stepwise analysis of variance of preoperative clinical data predictive of perioperative myocardial ischemia, intraoperative data such as aortic clamp time, incidence of coronary endarterectomy and number of grafts were comparable between patients with and without ischemia or conduction disturbances. However, it has to be mentioned that the overall low incidence of new RBBB and/or new MI in conjunction with the relatively low maximum CK and CK-MB values in those patients is in line with the assumption that the use of ante/retrograde blood cardioplegia may provide more effective intraoperative myocardial protection than crystalloid cardioplegic solutions [4,19,21,22]. This would also explain the fact that we did not observe relevant perioperative complications such as hemodynamic instability in patients with perioperative RBBB or even MI.
In conclusion, this study on patients undergoing coronary bypass grafting demonstrates that the perioperative occurrence of new transient or permanent RBBB is indicative of myocardial ischemia and is associated with myocardial cell necrosis. The extent of myocardial damage associated with new RBBB, however, appears less in comparison to patients with new MI and is not associated with significant hemodynamic complications during the early postoperative period.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
V. Birjiniuk Patient outcomes in the assessment of myocardial injury following cardiac surgery Ann. Thorac. Surg., December 1, 2001; 72(6): S2208 - 2212. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |